Related references
Note: Only part of the references are listed.Mammary Analogue Secretory Carcinoma of Salivary Glands With High-grade Transformation Report of 3 Cases With the ETV6-NTRK3 Gene Fusion and Analysis of TP53, beta-Catenin, EGFR, and CCND1 Genes
Alena Skalova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Molecular characterization of exosome-like vesicles from breast cancer cells
Stefan Kruger et al.
BMC CANCER (2014)
Consequences of using pooled versus individual samples for designing environmental monitoring sampling strategies
Anders Bignert et al.
CHEMOSPHERE (2014)
Data, information, knowledge and principle: back to metabolism in KEGG
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2014)
Microbial Dysbiosis Is Associated with Human Breast Cancer
Caiyun Xuan et al.
PLOS ONE (2014)
A Race Still Unfinished INTRODUCTION
Paula Kiberstis et al.
SCIENCE (2014)
Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance
Chao Zeng et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Primer on tumor immunology and cancer immunotherapy
Timothy J. Harris et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
Epigenetic field defects in progression to cancer
Carol Bernstein et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2013)
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Suzanne A. Eccles et al.
BREAST CANCER RESEARCH (2013)
The association of annexin A2 and cancers
Xiaohui Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Breast Cancer Exosome-like Microvesicles and Salivary Gland Cells Interplay Alters Salivary Gland Cell-Derived Exosome-like Microvesicles In Vitro
Chang S. Lau et al.
PLOS ONE (2012)
Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression
Charles F. Streckfus et al.
JOURNAL OF ONCOLOGY (2012)
Proteomic Analysis of Two Types of Exosomes in Human Whole Saliva
Yuko Ogawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
Helene Albert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Hasan Korkaya et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
Cecilia Lasser et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review
Paolo E. Porporato et al.
FRONTIERS IN PHARMACOLOGY (2011)
Mouse models of advanced spontaneous metastasis for experimental therapeutics
Giulio Francia et al.
NATURE REVIEWS CANCER (2011)
Epigenetics in breast cancer: what's new?
Yi Huang et al.
BREAST CANCER RESEARCH (2011)
Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling
Yogesh M. Kulkarni et al.
BMC CANCER (2010)
Large-scale proteomic identification of S100 proteins in breast cancer tissues
Patrizia Cancemi et al.
BMC CANCER (2010)
Annexin A1 expression and its prognostic significance in human breast cancer
L. P. Wang et al.
NEOPLASMA (2010)
S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer
N. R. West et al.
ONCOGENE (2010)
Annexin A1 regulates TGF-β signaling and promotes metastasis formation of basal-like breast cancer cells
Marjo de Graauw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PCNA on the crossroad of cancer
Ivaylo Stolimenov et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
Somaia E. Elsheikh et al.
CANCER RESEARCH (2009)
Statistical Design of Quantitative Mass Spectrometry-Based Proteomic Experiments
Ann L. Oberg et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Normalization and Statistical Analysis of Quantitative Proteomics Data Generated by Metabolic Labeling
Lily Ting et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
A HUPO test sample study reveals common problems in mass spectrometry-based proteomics
Alexander W. Bell et al.
NATURE METHODS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
PID: the Pathway Interaction Database
Carl F. Schaefer et al.
NUCLEIC ACIDS RESEARCH (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node Involvement
Charles F. Streckfus et al.
JOURNAL OF ONCOLOGY (2009)
Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast
Charles F. Streckfus et al.
CANCER INVESTIGATION (2008)
CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2
Wensheng Yang et al.
CELL CYCLE (2008)
S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast
Kazumori Arai et al.
CURRENT CANCER DRUG TARGETS (2008)
Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry
Louise Alldridge et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Heather R. Christofk et al.
NATURE (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
A. Jeanes et al.
ONCOGENE (2008)
Evaluation of biological pathways involved in chemotherapy response in breast cancer
Attila Tordai et al.
BREAST CANCER RESEARCH (2008)
The DNA damage response: Ten years after
J. Wade Harper et al.
MOLECULAR CELL (2007)
Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non-tumoral adjacent counterparts
Ida Pucci-Minafra et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Modelling breast cancer: one size does not fit all
Tracy Vargo-Gogola et al.
NATURE REVIEWS CANCER (2007)
Pattern of expression of genes linked to epigenetic silencing in human breast cancer
Kailas Munot et al.
HUMAN PATHOLOGY (2006)
Expanding the protein catalogue in the proteome reference map of human breast cancer cells
IP Minafra et al.
PROTEOMICS (2006)
Proteomic analysis in human breast cancer: Identification of a characteristic protein expression profile of malignant breast epithelium
G Hudelist et al.
PROTEOMICS (2006)
Heat shock proteins in cancer: chaperones of tumorigenesis
SK Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
MI Koukourakis et al.
CANCER RESEARCH (2006)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta
JP Sokol et al.
BREAST CANCER RESEARCH (2005)
Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer
BA Gusterson et al.
BREAST CANCER RESEARCH (2005)
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment -: A novel resource for biomarker and therapeutic target discovery
JE Celis et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Cdc25 phosphatases and cancer
K Kristjánsdóttir et al.
CHEMISTRY & BIOLOGY (2004)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast
RI Somiari et al.
PROTEOMICS (2003)
An approach to the proteomic analysis of a breast cancer cell line (SKBR-3)
SL Wu et al.
PROTEOMICS (2003)
Absence of constitutional H2AX gene mutations in 101 hereditary breast cancer families -: art. no. e51
ANA Monteiro et al.
JOURNAL OF MEDICAL GENETICS (2003)
Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions
A Ben-Baruch
BREAST CANCER RESEARCH (2003)
p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells
F Li et al.
EMBO REPORTS (2002)
Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage
T Ando et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma
C Streckfus et al.
CANCER INVESTIGATION (2000)
Share Paper
